BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Diagnosis
87 results:

  • 1. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
    Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
    Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
    Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
    J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Beyond BRCA: diagnosis and management of homologous recombination repair deficient pancreatic cancer.
    LaRose M; Manji GA; Bates SE
    Semin Oncol; 2024; 51(1-2):36-44. PubMed ID: 38171988
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment.
    Ikezawa K; Urabe M; Kai Y; Takada R; Akita H; Nagata S; Ohkawa K
    Jpn J Clin Oncol; 2024 Mar; 54(3):271-281. PubMed ID: 38109477
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Aneuploidy Landscape in Precursors of Ovarian cancer.
    Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
    Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rate of Pathogenic Germline Variants in Patients With Lung cancer.
    Sorscher S; LoPiccolo J; Heald B; Chen E; Bristow SL; Michalski ST; Nielsen SM; Lacoste A; Keyder E; Lee H; Nussbaum RL; Martins R; Esplin ED
    JCO Precis Oncol; 2023 Sep; 7():e2300190. PubMed ID: 37992258
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical features of germline brca1/2 or ATM pathogenic variant positive pancreatic cancer in Japan.
    Kitamura H; Morizane C; Tanabe N; Go I; Maruki Y; Ohba A; Nagashio Y; Kondo S; Hijioka S; Ueno H; Yoshida T; Okusaka T
    Pancreatology; 2023 Dec; 23(8):964-969. PubMed ID: 37914629
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Biallelic
    Wineland D; Le AN; Hausler R; Kelly G; Barrett E; Desai H; Wubbenhorst B; Pluta J; Bastian P; Symecko H; D'Andrea K; Doucette A; Gabriel P; Reiss KA; Nayak A; Feldman M; Domchek SM; Nathanson KL; Maxwell KN; ;
    JCO Precis Oncol; 2023 Aug; 7():e2300036. PubMed ID: 37535879
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Adherence to NCCN Genetic Testing Guidelines in pancreatic cancer and Impact on Treatment.
    Crowley F; Gandhi S; Rudshteyn M; Sehmbhi M; Cohen DJ
    Oncologist; 2023 Jun; 28(6):486-493. PubMed ID: 36933202
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer.
    Ceylan F; Guven DC; Taban H; Aktepe O; Sahin TK; Kilickap S; Turker A; Hamaloglu E; Karakoc D; Isik A; Akyol A; Yalcin S; Dizdar O
    Clin Res Hepatol Gastroenterol; 2023 Mar; 47(3):102091. PubMed ID: 36738855
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation.
    Okada K; Uemura K; Okamoto W; Sumiyoshi T; Shintakuya R; Otsuka H; Serikawa M; Ishii Y; Arihiro K; Takahashi S
    Clin J Gastroenterol; 2023 Apr; 16(2):283-288. PubMed ID: 36574187
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Metastatic colorectal cancer as the primary phenotype in a hereditary breast and ovarian cancer patient with Germline brca1 mutation: a case report.
    Liu Y; Zhu J; Wei X; Yang D; Li S; Qian X; Li L
    J Ovarian Res; 2022 Dec; 15(1):127. PubMed ID: 36463302
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prevalence of brca1 and BRCA2 pathogenic variants in 8627 unselected patients with breast cancer: stratification of age at diagnosis, family history and molecular subtype.
    Zang F; Ding X; Chen J; Hu L; Sun J; Zhang J; Xu Y; Yao L; Xie Y
    Breast Cancer Res Treat; 2022 Oct; 195(3):431-439. PubMed ID: 35974241
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Moderate penetrance genes complicate genetic testing for breast cancer diagnosis: ATM, CHEK2, BARD1 and RAD51D.
    Graffeo R; Rana HQ; Conforti F; Bonanni B; Cardoso MJ; Paluch-Shimon S; Pagani O; Goldhirsch A; Partridge AH; Lambertini M; Garber JE
    Breast; 2022 Oct; 65():32-40. PubMed ID: 35772246
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Leptomeningeal disease in BRIP1-mutated pancreatic adenocarcinoma.
    Yim E; Leung D
    BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35675963
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes.
    Gu L; Mehta PP; Rao D; Rotemberg V; Capanu M; Chou J; Lin S; Sigel CS; Busam KJ; Boyce L; Gordon A; O'Reilly EM
    Cancer Med; 2023 Jan; 12(1):179-188. PubMed ID: 35666021
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
    Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
    Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Development and validation of a prognostic nomogram for gallbladder cancer patients after surgery.
    Xu X; He M; Wang H; Zhan M; Yang L
    BMC Gastroenterol; 2022 Apr; 22(1):200. PubMed ID: 35448976
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Association of Pathogenic Variants in Hereditary cancer Genes With Multiple Diseases.
    Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
    JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. pancreatic Ductal Carcinoma Risk Associated With Hereditary cancer-Risk Genes.
    Gardiner A; Kidd J; Elias MC; Young K; Mabey B; Taherian N; Cummings S; Malafa M; Rosenthal E; Permuth JB
    J Natl Cancer Inst; 2022 Jul; 114(7):996-1002. PubMed ID: 35445726
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.